BioVex starts phase-I trial of genital herpes vaccine ImmunoVEXHSV2
Monday, March 08, 2010 14:00 IST Woburn, Massachusetts
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced that the first subject